Promote Sign in Sign up

Biotechnology

Tempus Labs

Tempus Labs is an AI-native company in Biotechnology, based in United States. Shown below: 1 tool, 16 funding rounds.

AI-native Not profitable Featured: Tempus US

$12.69B

Listed valuation

Visit website
Employees
3.8k
Raised
$1.05B
Valuation / employee
$3.34M
Tools
1
Rounds
16

Figures and classifications reflect imported catalog records, not live company reporting.

Tools

1 in the catalog

In the catalogs

6

Fundraises

Funding rounds

16 rounds

  • Debt Financing Announced 18 Feb 2025
    $300M Round Closed
  • IPO Announced 13 Jun 2024
    $410.70M Round $6.10B Post-money Closed
  • Series E+ Announced 30 Apr 2024 · Leads: SoftBank Group Corp.
    $200M Raised $200M Round 1 investors Closed
  • Series E+ Announced 11 Oct 2023
    $45M Round Closed
  • Debt Financing Announced 20 Oct 2022
    $275M Round Closed
  • Series E+ Announced 18 Apr 2022
    $85M Raised $85M Round 1 investors Closed
  • Convertible Note Announced 10 Dec 2020
    $250M Round Closed
  • Series E+ Announced 10 Dec 2020
    $200M Raised $200M Round $8.10B Post-money 5 investors Closed
  • Series E+ Announced 13 Mar 2020
    $100M Raised $100M Round $5B Post-money 5 investors Closed
  • Series E+ Announced 30 May 2019
    $200M Raised $200M Round $3.10B Post-money 6 investors Closed
  • Series E+ Announced 29 Aug 2018
    $110M Raised $110M Round $2B Post-money 4 investors Closed
  • Series D Announced 21 Mar 2018 · Leads: T. Rowe Price Investment Management
    $80M Raised $80M Round 4 investors Closed
  • Series C Announced 25 Sep 2017 · Leads: New Enterprise Associates, Revolution Growth
    $70M Raised $70M Round 2 investors Closed
  • Series B Announced 15 Nov 2016
    $10M Round Closed
  • Series B Announced 15 Jun 2016
    $10M Round Closed
  • Series A Announced 15 Sep 2015
    $10M Round Closed

Source rankings

Imported positions; not an independent quality score.

  • Overall Rank#173
  • AI Native Rank#50
  • Rank#84